ClomiPRAMINE Hydrochloride Capsules recall: Superpotent
ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004…
Why was ClomiPRAMINE Hydrochloride Capsules recalled?
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot#: B14221, Exp. Date 02/2023
- Product
- ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004…
- Recalling firm
- Leading Pharma, LLC
- Quantity
- 960 bottles (100 capsules)
- Distribution
- Nationwide within the United States
- Recall date
- October 5, 2022
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)